Organogenesis Holdings Inc. (ORGO)

NASDAQ

$1.00

$-0.02

(-1.96%)

Regular Market

Organogenesis Holdings Inc. (ORGO) Live Price Chart

Last updated: ⁦2026-10-21 16:22:40⁩. Prices reflect the latest regular market data. Stock price data is sourced from Massive.

Summary

Organogenesis Holdings Inc. (ORGO) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $1.01, with a market capitalization of $131.25M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.93 to $7.08. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$131.25M
Open	$1.04
Day's High	$310.90
Day's Low	$0.93
Previous Close	$1.02
Volume	326.10K
Average Volume	788.29K
P/E Ratio	--
52-Week High	$7.08
52-Week Low	$0.93
Dividend Yield	--
Earnings Date	--

Organogenesis Holdings Inc. (ORGO) Stock Price Today

Organogenesis Holdings Inc. (ORGO) is currently trading at $1.01 as of 2026-10-21 16:21:00, down 1.47% ($0.02) from the previous close of $1.02

During today's regular trading session, ORGO has traded between $0.93 and $310.90, with a trading volume of 326.10K shares. The current price is near the lower end of today's range.

Organogenesis Holdings Inc. (ORGO) 7-Day Stock Price Change

Over the past seven days, Organogenesis Holdings Inc. (ORGO) moved from $1.23 to $1.01, representing a decline of 18.29% ($0.23).

The stock traded between $0.93 and $1.28 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.

The average daily volume was 968.34 thousand shares, up versus the previous seven-day period, indicating higher trading activity.

ORGO 52-Week Price Position

Position in Range: 1.2%

52W Low$0.93

52W High$7.08

ORGO is currently trading at $1.01, placing it 1.2% of the way from its 52-week low of $0.93 to its 52-week high of $7.08. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Organogenesis Holdings Inc. (ORGO)?

Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.

Organogenesis Holdings Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	854
Exchange	NASDAQ
Company Website	https://www.organogenesis.com

How to Buy Organogenesis Holdings Inc. (ORGO) Stock on MEXC

Eligible investors can buy real shares of Organogenesis Holdings Inc. (ORGO) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for ORGO and Place Your Order

Open the RealStocks trading page and search for ORGO. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Organogenesis Holdings Inc. (ORGO) stock price today?

Organogenesis Holdings Inc. (ORGO) is currently trading at $ 1.01, down 1.47% ($0.02) from the previous close of $ 1.02. Intraday prices update in real time during regular trading hours.

2.Is ORGO stock going up or down today?

As of 2026-10-21 16:21:00, ORGO is trading at $ 1.01, down 1.47% ($0.02) from its previous close of $ 1.02. The stock has traded between $ 0.93 and $ 310.90 during today’s regular session. Past price movements do not guarantee future results.

3.What is ORGO pre-market price?

As of 2026-10-21 16:21:00, ORGO is trading at $ 1.03 in pre-market trading, up 1.37% ($0.01) from the previous close of $ 1.02. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is ORGO after-hours price?

As of 2026-10-21 16:21:00, ORGO is trading at $ 1.02 in after-hours trading, down 0.29% ($0.00) from the regular-session close of $ 1.02. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is ORGO stock trading now?

ORGO trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does ORGO sit relative to its 52-week high and low?

Over the past 52 weeks, ORGO has traded between a low of $ 0.93 and a high of $ 7.08. At $ 1.01, the stock is positioned 1.2% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Organogenesis Holdings Inc. in?

Organogenesis Holdings Inc. (ORGO) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Organogenesis Holdings Inc.'s market capitalization and where is it listed?

Organogenesis Holdings Inc. is listed on the NASDAQ exchange with a market capitalization of $ 131.25M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is ORGO valued in terms of P/E ratio and EPS?

ORGO trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -0.80. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Organogenesis Holdings Inc. pay a dividend?

Organogenesis Holdings Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.